Sid Gilman

10.7k citations
83 papers · 9k · 4 hit papers · h-index 31

Impact in

  • Neurology top 0.2%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Vestibular and auditory disorders
    • Neuroinflammation and Neurodegeneration Mechanisms
  • Physiology top 0.5%
    • Alzheimer's disease research and treatments

Papers in

    • Parkinson's Disease Mechanisms and Treatments 19
    • Neurological disorders and treatments 12
    • Vestibular and auditory disorders 7
    • Motor Control and Adaptation 17

Sid Gilman

83 papers receiving 8.5k citations

Sid Gilman's Hit Papers

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease 2009 · 646 citations
6460+7+15Years since publication5001k1.5k2k2.5k

Peers

Sid Gilman
Comparison fields: 5 of 119
  • Neurology 3.3k
  • Physiology 3.1k
  • Psychiatry and Mental health 1.4k
  • Neurology 614
  • Cellular and Molecular Neuroscience 558
Replace María Stamelou with:
María Stamelou Germany
Rocco Liguori Italy
Karlheinz Reiners Germany
Graham G Lennox United Kingdom
Paolo Livrea Italy
José Berciano Spain
Yasuomi Ouchi Japan
Giovanni Fabbrini Italy
John E. Duda United States
Steven J. Frucht United States
Sid Gilman relative to María Stamelou Germany María Stamelou's profile →
Citations per field
00.5×2×3×3.6×
María Stamelou · 1×
Citations per year

Countries citing papers authored by Sid Gilman

Since Specialization
Citations

This map shows the geographic impact of Sid Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sid Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sid Gilman more than expected).

Fields of papers citing papers by Sid Gilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sid Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sid Gilman. The network helps show where Sid Gilman may publish in the future.

Co-authors

The 25 scholars most cited alongside Sid Gilman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sid Gilman Line = papers co-authored together Sid Gilman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Second consensus statement on the diagnosis of multiple system atrophy
Hit paper breakdown →
20082616
2
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Hit paper breakdown →
20031156
3
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Hit paper breakdown →
20051108
4
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Hit paper breakdown →
2009646
5 2005470
6 1999278
7 2011223
8 2002178
9
Consensus statement on the diagnosis of multiple system atrophy.
1998161
10
The effect of chronic cerebellar stimulation upon epilepsy in man.
1973158
11 1993158
12 2010138
13 2003109
14 1990102
15 200090
16 200383
17 197372
18 197470
19 200566
20 199661

About Sid Gilman

Sid Gilman is a scholar working on Neurology, Neurology, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 83 papers that have together received 9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (19 papers), Motor Control and Adaptation (17 papers), Neurological disorders and treatments (12 papers), Neuroscience and Neuropharmacology Research (10 papers), Dementia and Cognitive Impairment Research (7 papers), Alzheimer's disease research and treatments (7 papers), Vestibular and auditory disorders (7 papers) and Genetic Neurodegenerative Diseases (4 papers). The work is most often cited by research in Neurology (3.3k citations), Physiology (3.1k citations), Psychiatry and Mental health (1.4k citations), Neurology (614 citations) and Cellular and Molecular Neuroscience (558 citations). Sid Gilman has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Nick C. Fox, Merçé Boada, Lachlan Kirby, M. Köller, Sue G. Griffith, Lisa Jenkins, Niall Patrick Quinn, Phillip A. Low, Gregor Karl Wenning and Thomas Klockgether. Their work appears in journals such as Neurology, Journal of Neural Transmission, Journal of Neurophysiology, Experimental Neurology and The Gerontologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact